Related Experiment Video

Updated: Feb 6, 2026

Culture of Bladder Cancer Organoids as Precision Medicine Tools
08:39

Culture of Bladder Cancer Organoids as Precision Medicine Tools

Published on: December 28, 2021

5.5K

Wnt signalling in gynaecological cancers: A future target for personalised medicine?

C E Ford1, C Henry1, E Llamosas1

  • 1Metastasis Research Group, Prince of Wales Clinical School, Lowy Cancer Research Centre, University of New South Wales, Australia.

Gynecologic Oncology
|October 4, 2015
PubMed

Insights

Personalized medicine remains elusive for ovarian, uterine, and cervical cancers. The Wnt signalling pathway presents a promising therapeutic target for these gynaecological malignancies.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Gynaecological cancers (ovarian, uterine, cervical) represent a significant global health burden.
  • Personalized medicine approaches are lacking in gynaecological cancer treatment.
  • Recent advances reveal the molecular underpinnings of these cancers, identifying key signaling pathways.

Purpose of the Study:

  • To review current research on the Wnt signaling pathway in ovarian, uterine, and cervical cancers.
  • To explore the potential of the Wnt pathway as a therapeutic target for personalized medicine in gynaecological oncology.

Main Methods:

  • Literature review of Wnt signaling pathway research in gynaecological cancers.
  • Analysis of molecular data from initiatives like The Cancer Genome Atlas.
  • Identification of potential therapeutic targets within the Wnt pathway, including ROR receptor tyrosine kinases.

Main Results:

  • The Wnt signaling pathway is implicated in all three major gynaecological cancers.
  • Alterations in the Wnt pathway are common in human malignancies.
  • ROR receptor tyrosine kinases are emerging as potential therapeutic targets within this pathway.

Conclusions:

  • The Wnt signaling pathway is a critical player in gynaecological cancers.
  • Targeting the Wnt pathway offers a potential avenue for developing personalized treatments.
  • Further research into Wnt pathway modulators could revolutionize gynaecological cancer therapy.
Keywords:
Cervical cancerOvarian cancerROR1ROR2Uterine cancerWnt

More Related Videos

Modeling Paracrine Noncanonical Wnt Signaling In Vitro11:14

Modeling Paracrine Noncanonical Wnt Signaling In Vitro

Published on: December 10, 2021

1.9K
Studying Wnt Signaling During Patterning of Conducting Airways13:00

Studying Wnt Signaling During Patterning of Conducting Airways

Published on: October 16, 2016

7.8K

Related Concept Videos

Canonical Wnt Signaling Pathway02:54

Canonical Wnt Signaling Pathway

The gene encoding the main signaling molecules of the Wnt signaling pathways (the Wnt proteins) was discovered almost four decades ago by Nüsslein-Volhard and Wieschaus. They identified and originally named the gene "wingless" (wg) after a phenotype discovered during their landmark genetic screen in Drosophila for body pattern defects. At around the same time, another researcher named Harold Varmus found that a murine tumor virus activates the mammalian wg homolog, Int-1, which...
10.7K
Non-Canonical Wnt Signaling Pathways01:41

Non-Canonical Wnt Signaling Pathways

Wnt is a zygotic effect gene that is expressed during very early embryonic development. It regulates various processes in animals starting from early development through the adult stage, such as organogenesis in the embryo and maintenance of neuronal and blood stem cells. Wnt proteins can induce a wide variety of intracellular pathways depending upon the specific abilities of different Wnt ligands to form a complex with shared and cognate receptors in the presence of different co-receptors. The...
8.5K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
8.9K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.8K
What is Cell Signaling?02:03

What is Cell Signaling?

Despite the protective membrane that separates a cell from the environment, cells need the ability to detect and respond to environmental changes. Additionally, cells often need to communicate with one another. Unicellular and multicellular organisms use a variety of cell signaling mechanisms to communicate to respond to the environment.
131.0K
Endocrine Signaling01:45

Endocrine Signaling

Endocrine cells produce hormones to communicate with remote target cells found in other organs. The hormone reaches these distant areas using the circulatory system. This exposes the whole organism to the hormone but only those cells expressing hormone receptors or target cells are affected. Thus, endocrine signaling induces slow responses from its target cells but these effects also last longer.
68.2K